https://www.selleckchem.com/pr....oducts/ro-31-8220-me
0 software. This study will provide high-quality evidence for the effectiveness and safety of XD in the treatment of NAFLD. The results of the study will help us determine whether XD can effectively treat NAFLD. This study does not require ethical approval. We will disseminate our findings by publishing results in a peer-reviewed journal. DOI 10.17605/OSF.IO/A5XEM. DOI 10.17605/OSF.IO/A5XEM. The objective is to analyze the clinical diagnosis and treatment of children with rescindable posterior encephalopathy syndrome (PRES)